Kathleen M. Mullane
Kaiser Permanente(US)
Publications by Year
Research Areas
Clostridium difficile and Clostridium perfringens research, Microscopic Colitis, Antifungal resistance and susceptibility, Fungal Infections and Studies, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → Fidaxomicin versus Vancomycin for Clostridium difficile Infection(2011)1,561 cited
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19(2020)1,265 cited
- → Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation(2017)1,163 cited
- → Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis(2016)679 cited
- → Posaconazole as Salvage Therapy for Zygomycosis(2005)553 cited
- → CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation